Fexofenadine-loaded chitosan coated solid lipid nanoparticles (SLNs): A potential oral therapy for ulcerative colitis
- 3 February 2024
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 196, 114205
Abstract
No abstract availableKeywords
Funding Information
- Academy of Scientific Research and Technology (130)
This publication has 84 references indexed in Scilit:
- Olmesartan niosomes ameliorates the Indomethacin-induced gastric ulcer in rats: Insights on MAPK and Nrf2/HO-1 signaling pathwayPharmaceutical Research, 2021
- Comparison between solid and liquid acids for production of low molecular weight chitosan using systematic DOE-based approachCellulose, 2018
- Formulation and characterization of solid lipid nanoparticles for an anti-retroviral drug darunavirApplied Nanoscience, 2017
- Current Status and New Perspectives on Chitin and Chitosan as Functional BiopolymersApplied Biochemistry and Biotechnology, 2016
- Antibacterial effects of chitosan–tripolyphosphate nanoparticles: impact of particle size molecular weightJournal of Nanoparticle Research, 2014
- Enhancement of Intestinal Permeability Utilizing Solid Lipid Nanoparticles Increases γ‐Tocotrienol Oral BioavailabilityLipids, 2012
- Role of phosphatidylinositol 3‐kinase in neuronal survival and axonal outgrowth of adult mouse dorsal root ganglia explantsJournal of Neuroscience Research, 2003
- Application of in vitro–in vivo correlations (IVIVC) in setting formulation release specificationsBiopharmaceutics & Drug Disposition, 2000
- In Vivo Evaluation of Controlled-Release ProductsJournal of Pharmaceutical Sciences, 1993
- Determination of CMC of Polysorbate 20 in Aqueous Solution by Surface Tension MethodJournal of Pharmaceutical Sciences, 1972